TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-ALPHA PRODUCTION IN CACHECTIC, TUMOR-BEARING MICE

被引:49
作者
LONNROTH, C
MOLDAWER, LL
GELIN, J
KINDBLOM, L
SHERRY, B
LUNDHOLM, K
机构
[1] GOTHENBURG UNIV,INST 1,DEPT SURG,S-41124 GOTHENBURG,SWEDEN
[2] GOTHENBURG UNIV,DEPT PATHOL,S-41124 GOTHENBURG,SWEDEN
[3] CORNELL UNIV,NEW YORK HOSP,COLL MED,DEPT SURG,SURG METAB LAB,NEW YORK,NY 10022
[4] ROCKEFELLER UNIV,MED BIOCHEM LAB,NEW YORK,NY 10021
关键词
D O I
10.1002/ijc.2910460523
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Weight‐stable mice bearing a syngeneic, methylcholanthrene‐induced, rapidly growing tumor lost approximately 22% of their lean tissue, became significantly hypoalbuminemic and had a marked increase in serum amyloid P concentrations during progressive tumor growth. Tumors from cachectic mice were producing both TNF‐α and IL‐1α in vivo as documented by the presence of TNF‐α and IL‐1α mRNA and immune‐reactive protein for IL‐1α. Only spleens from tumor‐bearing mice had statistically significantly elevated quantities of IL‐1 mRNA. In general, alterations in tissue concentrations of IL‐1 mRNA in tumor‐bearing animals agreed qualitatively with those found in endotoxin‐stimulated, nontumor‐bearing control mice. However, endotoxin‐stimulated mice had significantly elevated tissue concentrations of TNF mRNA in spleen and livers, while TNF mRNA levels were not significantly increased in any host tissues. Cytokine mRNA levels in tumor tissue were not higher than those found constitutively in various tissues from non‐tumor‐bearing control animals. Plasma from tumor‐bearing mice and endotoxinstimulated controls contained high levels of IL‐6 but low (endotoxin‐stim.) or no measurable levels (tumor‐bearing) of either IL‐1 or TNF. When tumor cells from cachectic mice were placed into long‐term cell culture, immune reactive TNF‐α and IL‐1α were produced, but IL‐6 bioactivity was not produced in measurable amounts. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:889 / 896
页数:8
相关论文
共 26 条
[1]  
BALKWILL F, 1987, LANCET, V2, P1229
[2]   GROWING TUMORS INDUCE HYPERSENSITIVITY TO ENDOTOXIN AND TUMOR-NECROSIS-FACTOR [J].
BARTHOLEYNS, J ;
FREUDENBERG, M ;
GALANOS, C .
INFECTION AND IMMUNITY, 1987, 55 (09) :2230-2233
[3]   IMMUNOCYTOCHEMICAL DETECTION OF INTERLEUKIN-1 WITHIN STIMULATED HUMAN-MONOCYTES [J].
BAYNE, EK ;
RUPP, EA ;
LIMJUCO, G ;
CHIN, J ;
SCHMIDT, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (05) :1267-1280
[4]   CACHECTIN AND TUMOR-NECROSIS-FACTOR AS 2 SIDES OF THE SAME BIOLOGICAL COIN [J].
BEUTLER, B ;
CERAMI, A .
NATURE, 1986, 320 (6063) :584-588
[5]   PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].
BEUTLER, B ;
MILSARK, IW ;
CERAMI, AC .
SCIENCE, 1985, 229 (4716) :869-871
[6]  
Carmichael G G, 1980, Methods Enzymol, V65, P380
[7]  
FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266
[8]   APPEARANCE OF HYBRIDOMA GROWTH-FACTOR INTERLEUKIN-6 IN THE SERUM OF MICE BEARING A METHYLCHOLANTHRENE-INDUCED SARCOMA [J].
GELIN, J ;
MOLDAWER, LL ;
LONNROTH, C ;
DEMAN, P ;
SVANBORGEDEN, C ;
LOWRY, SF ;
LUNDHOLM, KG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 157 (02) :575-579
[9]  
GELIN J, 1990, UNPUB ROLE ENDOGENOU
[10]  
GIRI JG, 1985, J IMMUNOL, V134, P343